Quinidine Therapy for Lennox-Gastaut Syndrome With KCNT1 Mutation. A Case Report and Literature Review

Frontiers in Neurology
Yu JiaYuping Wang

Abstract

Mutations in the Potassium channel subfamily T member 1 (KCNT1) gene have been reported in a range of epileptic encephalopathies. Here we report the case of a 12-year-old male suffering from multiple types of epileptic seizures and cognitive decline from the age of 10. The patient had four types of epileptic seizures, including tonic seizures, atypical absence seizures, myoclonic seizures, and generalized tonic-clonic seizures. The electroencephalogram showed generalized slow spike-and-slow-waves, mutiple-spike-and-slow-waves, as well as short-term fast rhythms bursts. Thus, he was diagnosed with Lennox-Gastaut syndrome. The patient had failed to control seizures after using five first-line antiepileptic drugs. Whole exome sequencing revealed a missense KCNT1 mutation (c.625 C>T). Previous studies revealed that quinidine could block the KCNT1 channel. Therefore, we assumed that quinidine might be effective for him. Add-on treatment with quinidine was started when the patient was 12 years old. After an 8-month treatment, the frequency of seizures and epileptiform discharges were significantly reduced. In conclusion, quinidine therapy may offer a new choice for the treatment of Lennox-Gastaut syndrome with KCNT1 mutations.

References

Nov 21, 2002·The Journal of Comparative Neurology·Arin BhattacharjeeLeonard K Kaczmarek
Jun 28, 2005·Trends in Neurosciences·Arin Bhattacharjee, Leonard K Kaczmarek
May 12, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Celia M SantiLawrence Salkoff
Aug 1, 2006·Neuropharmacology·Bo YangLeonard K Kaczmarek
Mar 5, 2014·Annals of Neurology·Carol J MilliganSteven Petrou
Jul 22, 2014·Annals of Neurology·David BeardenEthan M Goldberg
Aug 15, 2014·Frontiers in Cellular Neuroscience·Grace E Kim, Leonard K Kaczmarek
Jul 1, 2015·Epilepsia·Rikke S MøllerLeanne M Dibbens
Sep 16, 2015·Annals of Neurology·Mohamad A MikatiDavid Goldstein
Jan 11, 2016·Annals of Neurology·Pin Fee ChongRyutaro Kira
Sep 1, 2016·Brain & Development·Masataka FukuokaNaomichi Matsumoto
Oct 28, 2016·Zhonghua er ke za zhi. Chinese journal of pediatrics·K W ShangX R Wu
Jan 2, 2018·Seizure : the Journal of the British Epilepsy Association·Elie AbdelnourMohamad A Mikati

❮ Previous
Next ❯

Citations

Aug 11, 2020·Epilepsia·Sanjay M Sisodiya
Apr 23, 2020·Expert Review of Neurotherapeutics·Nicola SpecchioPaolo Curatolo
Jun 3, 2021·Trends in Pharmacological Sciences·Bethan A ColeJonathan D Lippiat

❮ Previous
Next ❯

Methods Mentioned

BETA
exome sequencing

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.